Research Article

Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19

Volume: 24 Number: 2 August 30, 2022
TR EN

Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19

Abstract

Aim: The epidemiological characteristics and modes of transmission of coronavirus disease 2019 (COVID-19) in children are not yet fully understood. In this study, it was aimed to evaluate clinical, laboratory, and radiological findings and treatment approaches in patients with negative and positive PCR tests among those with suspected COVID-19 retrospectively. Material and Methods: This study was conducted with 317 patients under 18 years of age, who received outpatient or inpatient treatment with a pre-diagnosis of COVID-19. All patients were assessed for clinical course, disease severity, comorbidity, demographic characteristics, laboratory and radiodiagnostic tests, treatment characteristics, and outcomes. Results: The PCR test was positive in 133 (42%) and negative in 184 (58%) of the patients with suspected COVID-19. There was a history of contact in 78 (58.6%) and 51 (27.7%) of the PCR-positive and negative patients, respectively (p<0.001). While the PCR-negative group had a higher rate of hospitalization (p=0.020), hospital stay was longer in PCR-positive cases (p=0.037). The white blood cell count (p=0.001), platelet count (p=0.037), neutrophil count (p=0.015), and lactate level (p=0.025) were significantly lower in the PCR-positive group. Conclusion: Early detection and isolation of children with symptoms suggestive of COVID-19 are important to limit the spread of the disease. It can be challenging initially to clinically understand whether the case has COVID-19, especially in pediatric patients. PCR test is the gold standard in the diagnosis of COVID-19. Considering the prevalence, severity, and complications of the outbreak, it would be a proper approach to initially evaluate suspected patients as COVID-19 patients.

Keywords

References

  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-207.
  2. Tan W, Zhao X, Ma X, Wang W, Niu P, Xu W, et al. A novel coronavirus genome identified in a cluster of pneumonia cases - Wuhan, China 2019-2020. China CDC Wkly. 2020;24;2(4):61-2.
  3. who.int [Internet]. World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief. [Cited: 2022 March 20]. Available from: https://apps.who.int/iris/handle/10665/331601
  4. saglik.gov.tr [Internet]. Republic of Türkiye Ministry of Health. COVID-19 Information Platform. [Cited: 2022 March 20]. Available from: https://covid19.saglik.gov.tr/
  5. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;15;395(10223):514-23.
  6. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42.
  7. CDC COVID-19 Response Team. Coronavirus disease 2019 in children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-6.
  8. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al.; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 Infection in children. N Engl J Med. 2020;382(17):1663-5.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

August 30, 2022

Submission Date

April 5, 2022

Acceptance Date

July 8, 2022

Published in Issue

Year 2022 Volume: 24 Number: 2

APA
Sav, N. M., Türay, S., Özde, Ş., & Öksüz, Ş. (2022). Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19. Duzce Medical Journal, 24(2), 162-169. https://doi.org/10.18678/dtfd.1098928
AMA
1.Sav NM, Türay S, Özde Ş, Öksüz Ş. Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19. Duzce Med J. 2022;24(2):162-169. doi:10.18678/dtfd.1098928
Chicago
Sav, Nadide Melike, Sevim Türay, Şükriye Özde, and Şükrü Öksüz. 2022. “Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19”. Duzce Medical Journal 24 (2): 162-69. https://doi.org/10.18678/dtfd.1098928.
EndNote
Sav NM, Türay S, Özde Ş, Öksüz Ş (August 1, 2022) Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19. Duzce Medical Journal 24 2 162–169.
IEEE
[1]N. M. Sav, S. Türay, Ş. Özde, and Ş. Öksüz, “Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19”, Duzce Med J, vol. 24, no. 2, pp. 162–169, Aug. 2022, doi: 10.18678/dtfd.1098928.
ISNAD
Sav, Nadide Melike - Türay, Sevim - Özde, Şükriye - Öksüz, Şükrü. “Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19”. Duzce Medical Journal 24/2 (August 1, 2022): 162-169. https://doi.org/10.18678/dtfd.1098928.
JAMA
1.Sav NM, Türay S, Özde Ş, Öksüz Ş. Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19. Duzce Med J. 2022;24:162–169.
MLA
Sav, Nadide Melike, et al. “Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19”. Duzce Medical Journal, vol. 24, no. 2, Aug. 2022, pp. 162-9, doi:10.18678/dtfd.1098928.
Vancouver
1.Nadide Melike Sav, Sevim Türay, Şükriye Özde, Şükrü Öksüz. Evaluation of Clinical Features and Treatment Results of Pediatric Patients With Pre-Diagnosis of COVID-19. Duzce Med J. 2022 Aug. 1;24(2):162-9. doi:10.18678/dtfd.1098928

Cited By